AI Terminal
Dr. Martens PLC
Director's Dealing • Feb 1, 2021
5055_dirs_2021-02-01_0b730ac6-5cff-432a-8e17-44d207dd4ac8.html
Director's Dealing
Open in ViewerOpens in native device viewer
National Storage Mechanism | Additional information 
RNS Number : 6206N
Dr. Martens PLC
01 February 2021
Director/PDMR Shareholding
Dr. Martens plc (the 'Company') announces that, as previously disclosed in the Company's Prospectus on 29 January 2021, the following transaction(s) in the Company's ordinary shares have been undertaken by directors / persons discharging managerial responsibility ('PDMRs').
1
Details of the person discharging managerial responsibilities/person closely associated
a)
Name
K Wilson
2
Reason for the notification
a)
Position/status
PDMR (Chief Executive Officer)
b)
Initial notification/Amendment
Initial notification
3
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)
Name
Dr. Martens plc
b)
LEI
213800QPT8YM6NQZPH28
4
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument, type of instrument
Identification code
Ordinary shares of GBP 0.01
ISIN: GB00BL6NGV24
b)
Nature of the transaction
Disposal of shares
c)
Price(s) and volume(s)
| Price(s) | Volume(s) |
| £3.70 | 5,523,125 |
d)
Aggregated information
| - | Aggregated volume |
| - | Price |
n/a (single transaction)
e)
Date of the transaction
29 January 2021
f)
Place of the transaction
London Stock Exchange, Main Market (XLON)
1
Details of the person discharging managerial responsibilities/person closely associated
a)
Name
P Mason
2
Reason for the notification
a)
Position/status
PDMR (Chairman)
b)
Initial notification/Amendment
Initial notification
3
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)
Name
Dr. Martens plc
b)
LEI
213800QPT8YM6NQZPH28
4
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument, type of instrument
Identification code
Ordinary shares of GBP 0.01
ISIN: GB00BL6NGV24
b)
Nature of the transaction
Disposal of shares
c)
Price(s) and volume(s)
| Price(s) | Volume(s) |
| £3.70 | 3,375,000 |
d)
Aggregated information
| - | Aggregated volume |
| - | Price |
n/a (single transaction)
e)
Date of the transaction
29 January 2021
f)
Place of the transaction
London Stock Exchange, Main Market (XLON)
1
Details of the person discharging managerial responsibilities/person closely associated
a)
Name
J Mortimore
2
Reason for the notification
a)
Position/status
PDMR (Chief Financial Officer)
b)
Initial notification/Amendment
Initial notification
3
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)
Name
Dr. Martens plc
b)
LEI
213800QPT8YM6NQZPH28
4
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument, type of instrument
Identification code
Ordinary shares of GBP 0.01
ISIN: GB00BL6NGV24
b)
Nature of the transaction
Disposal of shares
c)
Price(s) and volume(s)
| Price(s) | Volume(s) |
| £3.70 | 3,141,257 |
d)
Aggregated information
| - | Aggregated volume |
| - | Price |
n/a (single transaction)
e)
Date of the transaction
29 January 2021
f)
Place of the transaction
London Stock Exchange, Main Market (XLON)
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
DSHUAVNRAAUURAR